Hypertension in man is usually associated with increased renal vascular resistance. Cyclosporine, a new effective immunosuppressive agent, causes hypertension that is associated with markedly increased renal vascular resistance (RVR). This new form of drug induced hypertension has only recently been described and its pathophysiology has not been extensively studied. A protocol to compare various renal vascular vasodilator agents in humans to determine which one(s) are most effective in reversing cyclosporine induced renal vasoconstriction is presented. Renal transplant patients found to have hypertension (mean arterial pressure greater than 105 mmHg) and decreased renal blood flow less than 275 ml/min) will be placed on three different vasodilating drugs to determine which is most effective in decreasing renal vascular resistance A control group of equally hypertensive renal transplant patients not on cyclosporine (on azathioprine) with decreased renal blood flow will also be studied to determine if the vasodilator drug is specific in reversing cyclosporine induced renal vasoconstriction. These studies will be done in a General Clinical Research Center and changes in RVR measured using radioisotope techniques. In outpatients studies, drug levels of cyclosporine in patients will be measured (both by serum and whole blood RIA methods) and correlated to changes in renal vascular resistance over time. In studies of acute cyclosporine nephrotoxicity in rats the contribution of changes in glomerular hemodynamics, afferent and efferent arteriolar resistance and in renal neural activity to renal vasoconstriction and the fall in GFR will be examined. Expanded knowledge of the mechanisms of cyclosporine induced increases in blood pressure and renal vascular resistance can have a immediate impact on the clinical management of hypertension in organ transplant recipients. It also has potential to increase our knowledge about hypertension in general - especially that associated with changes in renal vascular resistance and sodium retention.

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Chambrey, R; Achard, J M; St John, P L et al. (1997) Evidence for an amiloride-insensitive Na+/H+ exchanger in rat renal cortical tubules. Am J Physiol 273:C1064-74
Wang, D; Balkovetz, D F; Warnock, D G (1995) Mutational analysis of transmembrane histidines in the amiloride-sensitive Na+/H+ exchanger. Am J Physiol 269:C392-402
Brown, S A; Finco, D R; Navar, L G (1995) Impaired renal autoregulatory ability in dogs with reduced renal mass. J Am Soc Nephrol 5:1768-74
Botero-Velez, M; Curtis, J J; Warnock, D G (1994) Brief report: Liddle's syndrome revisited--a disorder of sodium reabsorption in the distal tubule. N Engl J Med 330:178-81
Kudo, L H; Hawk, C T; Schafer, J A (1994) Sodium and water transport in cortical collecting duct of Dahl salt-resistant rat. Am J Physiol 267:F583-91
Lewis, J L; Warnock, D G (1994) Renal apical membrane sodium-hydrogen exchange in genetic salt-sensitive hypertension. Hypertension 24:491-8
Hawk, C T; Schafer, J A (1993) Clonidine, but not bradykinin or ANP, inhibits Na+ and water transport in Dahl SS rat CCD. Kidney Int 44:30-5
Hawk, C T; Kudo, L H; Rouch, A J et al. (1993) Inhibition by epinephrine of AVP- and cAMP-stimulated Na+ and water transport in Dahl rat CCD. Am J Physiol 265:F449-60
Allon, M; Parris, M (1993) Calcitriol stimulates Na(+)-Pi cotransport in a subclone of opossum kidney cells (OK-7A) by a genomic mechanism. Am J Physiol 264:F404-10
Wuthrich, R P; Jenkins, T A; Snyder, T L (1993) Regulation of cytokine-stimulated vascular cell adhesion molecule-1 expression in renal tubular epithelial cells. Transplantation 55:172-7

Showing the most recent 10 out of 74 publications